The first vaccine against malaria to undergo wide-scale testing shows that youngsters who got it were about half as likely to come down with the disease over a 14-month follow-up period as were those who didn’t receive the vaccine.
An international group of scientists report the findings online October 18 in the New England Journal of Medicine.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.